Summary

Stem Cell Innovations, Inc. (SCI) is a privately held biotechnology company, based in the US. The company is engaged in the discovery and development of human cell based drugs. Its core technologies concentrate on developing, growing, and manipulating human cells in the laboratory using proprietary technology. The company is into the development of a broad array of human primary cell models, which can be used as powerful research tools to form the basis of therapeutic breakthroughs. SCI has established many human pluripotent stem cell lines fetal gonadal tissue using defined conditions, and the PluriCell lines are established directly onto tissue culture plastic without using feeder layers or conditioned medium. The company also has in vitro hepatocyte screening, kits, compositions, and services for compound toxicity testing, ACTIVTox and PREDICTIVTox in store. SCI is headquartered at Houston in Texas, the US.

Stem Cell Innovations, Inc. (SCLL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

Table Of Contents

Stem Cell Innovations, Inc. (SCLL) - Pharmaceuticals and Healthcare - Deals and Alliances Profile
Table of Contents

Table of Contents 2
List of Tables 3
List of Figures 3
Stem Cell Innovations, Inc., Pharmaceuticals and Healthcare, Deals By Year, 2007 to YTD 2013 4
Stem Cell Innovations, Inc., Pharmaceuticals and Healthcare Deals By Type, 2007 to YTD 2013 5
Stem Cell Innovations, Inc., Pharmaceuticals and Healthcare, Deals By Region, 2007 to YTD 2013 6
Stem Cell Innovations, Inc., Pharmaceuticals and Healthcare, Deals By Therapy Area, 2007 to YTD 2013 7
Stem Cell Innovations, Inc., Pharmaceuticals and Healthcare, Deals Summary, 2007 to YTD 2013 8
Stem Cell Innovations, Inc., Pharmaceuticals and Healthcare, Deal Details 9
Partnerships 9
High Q Foundation Enters Into Co-Development Agreement With Stem Cell 9
Stem Cell Enters Into Collaboration Agreement With TNO 10
Licensing Agreements 11
Pluristem Enters Into Licensing Agreement With Stem Cell Innovations For PLX I Technology 11
Pluristem Enters Into Technology Licensing Agreement With Stem Cell Innovations 12
Stem Cell Innovations, Inc. - Key Competitors 13
Locations And Subsidiaries 14
Head Office 14
Appendix 15
Methodology 15
About GlobalData 15
Contact Us 15
Disclaimer 15



List of Tables

Stem Cell Innovations, Inc., Pharmaceuticals and Healthcare, Key Facts 1
Stem Cell Innovations, Inc., Pharmaceuticals and Healthcare, Deals By Year, 2007 to YTD 2013 1
Stem Cell Innovations, Inc., Pharmaceuticals and Healthcare, Deals By Region, 2007 to YTD 2013 1
Stem Cell Innovations, Inc., Pharmaceuticals and Healthcare, Deals By Therapy Area, 2007 to YTD 2013 1
Stem Cell Innovations, Inc., Pharmaceuticals and Healthcare, Deals By Year, 2007 to YTD 2013 4
Stem Cell Innovations, Inc., Pharmaceuticals and Healthcare Deals By Type, 2007 to YTD 2013 5
Stem Cell Innovations, Inc., Pharmaceuticals and Healthcare, Deals By Region, 2007 to YTD 2013 6
Stem Cell Innovations, Inc., Deals By Therapy Area, 2007 to YTD 2013 7
Stem Cell Innovations, Inc., Pharmaceuticals and Healthcare, Deals Summary, 2007 to YTD 2013 8
High Q Foundation Enters Into Co-Development Agreement With Stem Cell 9
Stem Cell Enters Into Collaboration Agreement With TNO 10
Pluristem Enters Into Licensing Agreement With Stem Cell Innovations For PLX I Technology 11
Pluristem Enters Into Technology Licensing Agreement With Stem Cell Innovations 12
Stem Cell Innovations, Inc., Key Competitors 13



List of Figures

Stem Cell Innovations, Inc., Pharmaceuticals and Healthcare, Deals by Type, 2007 to YTD 2013 1
Stem Cell Innovations, Inc., Pharmaceuticals and Healthcare, Deals By Year, 2007 to YTD 2013 4
Stem Cell Innovations, Inc., Pharmaceuticals and Healthcare, Deals by Type, 2007 to YTD 2013 5
Stem Cell Innovations, Inc., Pharmaceuticals and Healthcare, Deals By Region, 2007 to YTD 2013 6
Stem Cell Innovations, Inc., Pharmaceuticals and Healthcare, Deals By Therapy Area, 2007 to YTD 2013 7

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Clare

+1 339 368 6001

Purchase Reports From Reputable Market Research Publishers

International Stem Cell Corporation (ISCO) - Financial and Strategic SWOT Analysis Review

International Stem Cell Corporation (ISCO) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • April 2015
  • by Global Data

Summary International Stem Cell Corporation (ISCC) is a biotechnology company. The company develops parthenogenesis, a stem cell technology that advances the field of regenerative medicine. It develops ...

California Stem Cell, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

California Stem Cell, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • March 2015
  • by Global Data

Summary California Stem Cell, Inc. (CSC) is a biotechnology company. The company produces and supplies clinically relevant human cell populations and therapeutic application to human disease and injury. ...

VistaGen Therapeutics , Inc. - Product Pipeline Review - 2015

VistaGen Therapeutics , Inc. - Product Pipeline Review - 2015

  • $ 1 500
  • Company report
  • April 2015
  • by Global Markets Direct

VistaGen Therapeutics , Inc. - Product Pipeline Review - 2015 Summary Global Markets Direct’s, ‘VistaGen Therapeutics , Inc. - Product Pipeline Review - 2015’, provides an overview of the VistaGen ...


ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.